Literature DB >> 9795783

CRP levels in autoimmune disease can be specified by measurement of procalcitonin.

V Schwenger1, J Sis, A Breitbart, K Andrassy.   

Abstract

Autoimmune diseases (AID) are prone to infection particularly under immunosuppression. The differentiation of infection from active AID is often difficult. In order to specify the diagnostic value of measurement of procalcitonin (PCT) in AID 81 patients with anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis were analyzed, 27 with rheumatoid arthritis and 25 patients with systemic lupus erythematosus at various stages of the disease. Although PCT levels (95th percentile) were below 0.5 ng/ml in patients with active systemic lupus erythematosus and rheumatoid arthritis, the cutoff for normal values (95th percentile) in patients with active ANCA-positive vasculitis was 0.89. Therefore PCT levels of < 1 ng/ml are recommended as cutoff for invasive infections in patients with ANCA-positive vasculitis. In view of the increased mortality under immunosuppression in patients with AID and additional bacterial infection the measurement of PCT is helpful when an infectious origin is suspected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795783     DOI: 10.1007/bf02962246

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  13 in total

1.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

Review 2.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

3.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

4.  Infectious complications of cyclophosphamide treatment for vasculitis.

Authors:  J D Bradley; K D Brandt; B P Katz
Journal:  Arthritis Rheum       Date:  1989-01

Review 5.  Infectious complications in the management of systemic vasculitis and rapidly progressive glomerulonephritis.

Authors:  G H Neild
Journal:  APMIS Suppl       Date:  1990

6.  ANCA in haemodialysis patients.

Authors:  S Weidemann; K Andrassy; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

7.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11

8.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

Review 9.  Procalcitonin--a new indicator of the systemic response to severe infections.

Authors:  W Karzai; M Oberhoffer; A Meier-Hellmann; K Reinhart
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

10.  Procalcitonin, a marker of bacterial infection.

Authors:  D Gendrel; C Bohuon
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

View more
  10 in total

Review 1.  Validation of new biomarkers in systemic autoimmune diseases.

Authors:  Maria G Tektonidou; Michael M Ward
Journal:  Nat Rev Rheumatol       Date:  2011-11-01       Impact factor: 20.543

Review 2.  Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.

Authors:  Ilaria Serio; Laurent Arnaud; Alexis Mathian; Pierre Hausfater; Zahir Amoura
Journal:  Clin Rheumatol       Date:  2014-07-27       Impact factor: 2.980

3.  The value of procalcitonin measurements in children with familial Mediterranean fever.

Authors:  Selçuk Yüksel; Mesiha Ekim; Z Birsin Ozçakar; Fatoş Yalçınkaya; Banu Acar; Derya Oztuna; Nejat Akar
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

4.  The relationship between procalcitonin and thyroid autoantibodies in patients with autoimmune thyroiditis.

Authors:  Ali Oncul; Ihsan Ates; Mehmet Fettah Arikan; Nisbet Yilmaz; Canan Topcuoglu; Fatma Meric Yilmaz; Mustafa Altay
Journal:  J Clin Lab Anal       Date:  2017-02-07       Impact factor: 2.352

5.  Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

Authors:  I Delèvaux; M André; M Colombier; E Albuisson; F Meylheuc; R-J Bègue; J-C Piette; O Aumaître
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

6.  Dual-Quantum-Dots-Labeled Lateral Flow Strip Rapidly Quantifies Procalcitonin and C-reactive Protein.

Authors:  XiaoPing Qi; YunYe Huang; ZhongShi Lin; Liang Xu; Hao Yu
Journal:  Nanoscale Res Lett       Date:  2016-03-25       Impact factor: 4.703

Review 7.  [Procalcitonin in the intensive care unit : Differential diagnostic and differential therapeutic possibilities].

Authors:  S Großmann; S Schroll; M Pfeifer
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-06-29       Impact factor: 0.840

8.  Procalcitonin levels in patients with complete and incomplete Kawasaki disease.

Authors:  Hwa Jin Cho; Young Earl Choi; Eun Song Song; Young Kuk Cho; Jae Sook Ma
Journal:  Dis Markers       Date:  2013-10-10       Impact factor: 3.434

9.  Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.

Authors:  Chou-Han Lin; Song-Chou Hsieh; Li-Ta Keng; Ho-Sheng Lee; Hou-Tai Chang; Wei-Yu Liao; Chao-Chi Ho; Chong-Jen Yu
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

10.  Modestly Elevated Serum Procalcitonin Levels in Patients with Rheumatoid Arthritis Free of Active Infection.

Authors:  Khai-Jing Ng; Hui-Chun Yu; Hsien-Yu Huang Tseng; Chia-Wen Hsu; Ming-Chi Lu
Journal:  Medicina (Kaunas)       Date:  2020-10-17       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.